In the dynamic life sciences clinical development field, patient engagement has emerged a vital innovation and success driver. As clinical research evolves, integrating patient perspectives and active participation has become a transformative force, significantly enhancing clinical trials’ quality and relevance. Effective patient engagement throughout the clinical trial process, from study design and recruitment to data collection and result dissemination, ensures that trials are more patient-centric, efficient, and likely to yield meaningful insights.
Patient engagement in clinical development is not merely a regulatory requirement but a strategic imperative. Patients who are engaged are more likely to participate in clinical trials and remain committed throughout the study, thereby reducing dropout rates and accelerating the research timeline.
In this report, we assess start-ups that provide clinical trial patient engagement solutions, offering insights into capabilities, market impact, and the evolving landscape. Furthermore, from creating patient advisory boards to using patient-reported outcomes, we will explore practical strategies to incorporate patient engagement into clinical development. We will also examine case studies and best practices that illustrate patient-centric approaches’ tangible benefits.
Scope
Industry: life sciences
Geography: global
Contents
In this report, we
Examine the drivers and barriers to patient engagement solution adoption in clinical trials
Introduce a framework to evaluate high-potential start-ups in the patient engagement market
Highlight the trailblazers in patient engagement, including their assessment, leaderboard, and profiles
